Nebivolol Teva (Nebivolol Hydrochloride)

Nebivolol, the active ingredient in Nebivolol Teva, is a beta‑blocker presented as a tablet for oral use. It treats hypertension in adult patients.

GNH USA supplies Nebivolol Teva as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nebivolol is a selective β1‑adrenergic antagonist used in the management of cardiovascular conditions.

- Essential hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Stage 1 hypertension: achieves target blood pressure when lifestyle measures are insufficient. - Stage 2 hypertension: provides additional pressure reduction in patients requiring multiple agents.

Nebivolol may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Headache: mild to moderate pain often occurring early in therapy. - Dizziness or light‑headedness: related to blood pressure reduction. - Fatigue: general tiredness, especially after dose initiation. - Bradycardia: slower than normal heart rate. - Peripheral edema: mild swelling of ankles or feet. - Nasal congestion: sensation of a blocked nose.

Serious or Rare Side Effects: - Severe bradycardia: heart rate dropping to dangerously low levels. - Atrioventricular block: impaired electrical conduction requiring monitoring. - Bronchospasm: airway constriction, particularly in asthmatic patients. - Allergic reactions: rash, itching, or anaphylaxis. - Hepatic dysfunction: abnormal liver enzymes or jaundice. - Acute heart failure exacerbation: worsening symptoms of cardiac insufficiency.

Before initiating Nebivolol, consider patient‑specific factors and monitor appropriately.

- Renal impairment: dose may need adjustment and renal function should be monitored. - Hepatic impairment: use with caution; monitor liver enzymes. - Asthma or COPD: avoid or use only if benefits outweigh risks due to β‑blockade. - Pregnancy: safety not established; avoid unless clearly needed. - Concomitant AV‑nodal blockers: monitor heart rate and rhythm closely. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Nebivolol can interact with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Other β‑blockers: additive bradycardia and hypotension. - Calcium channel blockers (verapamil, diltiazem): increased risk of AV block. - Clonidine: abrupt withdrawal may cause rebound hypertension.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may enhance hypotensive effect. - Diuretics: risk of orthostatic hypotension and electrolyte imbalance. - NSAIDs: may reduce antihypertensive efficacy. - Antidiabetic agents: may mask hypoglycemia symptoms.